Use of a Highly Antioxidant Diet in the Regulation of Adipose Tissue Secretion in Patients after the BIB Procedure
- PMID: 34067712
- PMCID: PMC8156671
- DOI: 10.3390/foods10051108
Use of a Highly Antioxidant Diet in the Regulation of Adipose Tissue Secretion in Patients after the BIB Procedure
Abstract
Obesity is a global problem. The secretory activity of adipose tissue causes inflammation and disturbs metabolic parameters. Low-invasive bariatric procedures are an alternative to surgical treatment, especially in individuals who do not qualify for surgery or in whom conservative treatment does not bring the expected results. The diets designed for bariatric patients contained an increased proportion of bioflavonoids. The dietary components were carefully selected to provide anti-inflammatory effects. The experimental diets showed an antioxidant capacity (TEAC) of 433-969 µM TE/100 g or 100 mL, reducing ability (FRAP) of 13-58 µM TE/100 g or 100 mL, and total polyphenol content of 80-250 mg catechins/100 g or 100 mL. Lower levels of adipocytokines were obtained in the blood of patients following the diet. The results of the present study showed the participation of some adipocytokines in the regulation of energy homeostasis, lipid metabolism, glucose level, blood pressure and inflammation. Diet therapy should yield positive results in the long term, with the possibility of using immune modulation in personalized therapy for metabolic syndrome.
Keywords: 8-isoprostane; AGT; BIB (BioEnterics Intragastric Balloon); IL-1; IL-6; PAI-1; TNF-α; antioxidants; metabolic diseases; obesity.
Conflict of interest statement
The authors declare no conflict of interest.
Similar articles
-
Assessment of the Effect of Dietary Modifications and Bioenteric Intragastric Balloon Treatment on the Changes of Some Morphological and Biochemical Parameters in Obese Patients.Ann Nutr Metab. 2018;73(4):290-301. doi: 10.1159/000493274. Epub 2018 Oct 26. Ann Nutr Metab. 2018. PMID: 30368499
-
BioEnterics Intragastric Balloon (BIB): a short-term, double-blind, randomised, controlled, crossover study on weight reduction in morbidly obese patients.Int J Obes (Lond). 2006 Jan;30(1):129-33. doi: 10.1038/sj.ijo.0803094. Int J Obes (Lond). 2006. PMID: 16189503 Clinical Trial.
-
Circulating SIRT1 Increases After Intragastric Balloon Fat Loss in Obese Patients.Obes Surg. 2016 Jun;26(6):1215-20. doi: 10.1007/s11695-015-1859-4. Obes Surg. 2016. PMID: 26337692
-
Position of intragastric balloons in global initiative for obesity treatment.Coll Antropol. 2011 Dec;35(4):1353-62. Coll Antropol. 2011. PMID: 22397287 Review.
-
Intragastric Balloon (BIB system) in the treatment of obesity and preparation of patients for surgery - own experience and literature review.Pol Przegl Chir. 2011 Apr;83(4):181-7. doi: 10.2478/v10035-011-0028-2. Pol Przegl Chir. 2011. PMID: 22166356 Review.
Cited by
-
Antioxidant in Food Safety and Sustainability.Foods. 2022 Feb 1;11(3):433. doi: 10.3390/foods11030433. Foods. 2022. PMID: 35159582 Free PMC article.
References
-
- Keaver L., Webber L., Dee A., Shiely F., Marsh T., Balanda K., Perry I.J. Application of the UK Foresight Obesity Model in Ireland: The Health and Economic Consequences of Projected Obesity Trends in Ireland. [(accessed on 13 March 2013)];2013 Available online: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3827424. - PMC - PubMed
-
- Manu P., Chandni R., Devarajan E.A. Study on Estimation of Visceral Fat and Its Metabolic and Clinical Correlates in Metabolic Syndrome. Clin. Proc. 2017;13:6–13.
-
- Allahverdi T.D. Obesity. IntechOpen; London, UK: 2020. Treatment Options in Morbid Obesity.
-
- Sjöström L., Gummesson A., Sjöström C.D., Narbro K., Peltonen M., Wedel H., Bengtsson C., Bouchard C., Carlsson B., Dahlgren S., et al. Swedish obese subjects study. Effects of bariatric surgery on mortality in swe-dish obese study. N. Engl. J. Med. 2007;8:741–752. doi: 10.1056/NEJMoa066254. - DOI - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous